TRGM Financials 07/15/2014 23:39:45 Targeted Medi

TRGM Financials 07/15/2014 23:39:45
Targeted Medical Pharma, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 9,556 7,296 8,810 7,622
Cost of Revenue 2,989 3,201 2,757 2,572
Gross Profit 6,566 4,095 6,053 5,050
Operating Expenses
Research and Development 229 134 163 320
Sales, General and Admin. 10,179 10,101 11,670 6,306
Non-Recurring Items - - - -
Other - - - -
Operating Income (3,841) (6,140) (5,781) (1,576)
Income From Continuing Operations
Add'l Income/Expense Items 159 (4,433) 8 737
Earnings Before Interest and Tax (3,671) (12,772) (6,649) (839)
Interest Expense - - - -
Earnings Before Tax (3,671) (12,772) (6,649) (839)
Income Tax 5,667 (3,186) (2,472) (332)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (9,338) (9,586) (4,177) (506)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (9,338) (9,586) (4,177) (506)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (9,338) (9,586) (4,177) (506)